Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pneumococcal pneumonia resistant to penicillin].

V Garrait1, T Vassal, V Barakett

  • 1Service de Réanimation Polyvalente, Hôpital Saint-Antoine, Paris, France.

Revue De Pneumologie Clinique
|January 1, 1991
PubMed
Summary

Community-acquired pneumonia in COPD patients can be complicated by antibiotic-resistant Streptococcus pneumoniae. This case highlights the need for careful antibiotic selection and monitoring due to emerging penicillin resistance in pneumococcus.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Frailty assessment in critically ill older adults: a narrative review.

Annals of intensive care·2024
Same author

[Discussion about the presentation:"Intensive care and Covid"].

Bulletin de l'Academie nationale de medecine·2022
Same author

[Intensive care and Covid].

Bulletin de l'Academie nationale de medecine·2021
Same author

Less contact isolation is more in the ICU: not sure.

Intensive care medicine·2019
Same author

Blood donations mode: Assessment of the Lebanese model.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2019
Same author

Does region of origin influence the timing and outcome of first-line antiretroviral therapy in France?

HIV medicine·2018

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Clinical Microbiology

Background:

  • Community-acquired pneumonia (CAP) is a significant cause of morbidity and mortality, particularly in patients with chronic obstructive lung disease (COPD).
  • Antibiotic resistance, especially among Streptococcus pneumoniae, poses a growing challenge in treating respiratory infections.

Observation:

  • A patient with COPD developed CAP and was initially treated with amoxicillin-clavulanic acid and intravenous macrolides.
  • Blood cultures identified Streptococcus pneumoniae, and antibiotic therapy was switched to amoxicillin alone pending sensitivity results.
  • The patient experienced rapid clinical deterioration, indicating amoxicillin resistance of the pathogen.

Findings:

  • The identified pneumococcus strain demonstrated resistance to amoxicillin, leading to treatment failure with monotherapy.

Related Experiment Videos

  • Subsequent treatment with erythromycin resulted in patient recovery, confirming the pathogen's susceptibility to macrolides.

    • Implications:

    • This case underscores the critical issue of emerging penicillin-resistant Streptococcus pneumoniae in CAP management.
    • Judicious antibiotic selection and susceptibility testing are crucial for effective treatment of CAP in vulnerable populations like COPD patients.
    • The findings necessitate a re-evaluation of empirical antibiotic strategies for CAP, considering local resistance patterns.